Fingerprint
Dive into the research topics where Karthik Giridhar is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
ASO Visual Abstract: Validation of the Performance of the Novel Prognostic Staging System for Overall Survival in De Novo Metastatic Breast Cancer and Demonstration of Performance for Cancer-Specific Outcomes
Vetter, C. D., Hoskin, T., Olson, C., Giridhar, K. & Boughey, J. C., Jan 1 2026, In: Annals of surgical oncology. 33, 1, p. 176-177 2 p.Research output: Contribution to journal › Article › peer-review
-
Imlunestrant, an oral selective estrogen receptor degrader, in combination with HER2 directed therapy, with or without abemaciclib, in ER-positive, HER2-positive advanced breast cancer: results from the phase 1a/1b EMBER study
Bhave, M., Jhaveri, K. L., Kaufman, P. A., Aftimos, P., Lombard, J., Giridhar, K. V., Im, S. A., Ma, C. X., Lee, K. T., Kim, S. B., Sohn, J., Li, Y., Yuen, E., Estrem, S. T., Nguyen, B., Makena, M. R., Ismail-Khan, R. & Beeram, M., Dec 2026, In: Breast Cancer Research. 28, 1, 18.Research output: Contribution to journal › Article › peer-review
Open Access -
Plasma assay of methylated DNA markers detects recurrent metastatic breast cancer
Giridhar, K. V., Sinnwell, J. P., Slettedahl, S. W., Taylor, W. R., Mahoney, D. W., Foote, P. H., O’Connell, M. C., Robran, M. J., Devens, M. E., Gonser, A. M., Larson, N. L., Doering, K. A., Burger, K. N., Kaiser, M. W., Allawi, H. T., Ruddy, K. J., Olson, J. E., Couch, F. J. & Kisiel, J. B., Dec 2026, In: npj Breast Cancer. 12, 1, 2.Research output: Contribution to journal › Article › peer-review
Open Access -
Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis
Janni, W., Friedl, T. W. P., Yab, T. C., Bidard, F. C., Cristofanilli, M., Hayes, D. F., Ignatiadis, M., Regan, M. M., Alix-Panabieres, C., Barlow, W. E., Caldas, C., Carey, L. A., Dirix, L., Fehm, T., Garcia-Saenz, J. A., Gazzaniga, P., Generali, D., Gerratana, L., Gisbert-Criado, R. & Jacot, W. & 23 others, , Jun 1 2025, In: Clinical Cancer Research. 31, 11, p. 2196-2209 14 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Combined prognostic impact of initial clinical stage and residual cancer burden after neoadjuvant systemic therapy in triple-negative and HER2-positive breast cancer: an analysis of the I-SPY2 randomized clinical trial
Leon-Ferre, R. A., Dimitroff, K., Yau, C., Giridhar, K. V., Mukhtar, R., Hirst, G., Hylton, N., Perlmutter, J., DeMichele, A., Yee, D., van ’t Veer, L., Rugo, H., Symmans, W. F., Goetz, M. P., Esserman, L. & Boughey, J. C., Dec 2025, In: Breast Cancer Research. 27, 1, 115.Research output: Contribution to journal › Article › peer-review
Open Access